Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Management of New Septated Ovarian Cyst in Postmenopausal Woman

Risk Assessment

  • The risk of malignancy in simple ovarian cysts is extremely low: approximately 1.5% in postmenopausal women with surgically removed unilocular cysts 1
  • Cyst size remains small, well below the 10 cm threshold where malignancy risk increases to 1-10% 1
  • A CT scan showing no concerning findings provides additional reassurance against malignancy 3
  • For postmenopausal women with septated cysts >3 cm but <10 cm, continue annual ultrasound surveillance showing stability or decrease in size for at least 1 year 1, 2
  • Consider extending annual follow-up for up to 5 years if the cyst remains stable 1, 2
  • Transvaginal ultrasound is the preferred imaging modality for follow-up 1
  • Indications for gynecologic referral include cyst enlargement on follow-up imaging 2, development of solid components, papillary projections, or ascites 3, and progressive elevation of CA125 over time 3, 4, 5
  • Cyst size approaching or exceeding 10 cm is also an indication for gynecologic referral 1

Important Clinical Context

  • The ESMO guidelines note that features highly suggestive of advanced ovarian cancer include complex masses with both solid and cystic components, internal echoes, septations, ascites, or peritoneal metastases 3, 4, 5
  • Septations alone in the context of small cyst size, normal/declining CA125, and negative CT imaging do not warrant immediate surgical intervention
  • The specificity of CA125 testing is 98.5% for women over age 50, and women who ultimately develop ovarian cancer demonstrate progressive elevation of CA125 over time rather than stable or declining values 3, 4, 5

Critical Pitfalls to Avoid

  • Overtreatment of small cysts in postmenopausal women, as evidence shows they rarely represent malignancy and can be safely followed 1
  • Fine-needle aspiration of ovarian masses is contraindicated and should not be performed 6
  • Failure to perform follow-up at appropriate intervals (annual surveillance for postmenopausal women with cysts >3 cm) 1, 2
  • Ignoring the trend in CA125 values—progressive elevation is the concerning pattern, not stable or declining values 3, 4, 5